ICE vs OGEN · P/E 37, rev $12.64B vs rev $37.7K
Intercontinental Exchange Inc (ICE) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported ICE revenue for 2025-12-31 was $12.64B. Net income was $3.31B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
ICE currently screens at market cap $103.55B and trailing P/E 37.3. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the ICE and OGEN stock pages for the full models.
Not investment advice.